# Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

> **NCT03986528** · PHASE4 · UNKNOWN · sponsor: **Jie Li** · enrollment: 334 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Kanglaite Injection+Chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03986528
- **Lead sponsor:** Jie Li
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-28
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 334 (ESTIMATED)
- **Last updated:** 2021-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986528, "Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03986528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*